Dr. Wakelee on Using Lymph Nodes for Lung Cancer Staging

Video

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Using Lymph Nodes for Lung Cancer Staging

Heather Wakelee, MD, assistant professor, Department of Medicine, Division of Oncology, Stanford University, Stanford Clinical Cancer Center, describes the importance of lymph nodes for staging lung cancer.

Wakelee explains that tumor specific features and metastasis can be identified after surgery. Lymph nodes removed during surgery are the most accurate way to determine the stage of the lung cancer, despite many non-invasive methods gaining in popularity.

At this point there is not an adequate amount of nodal dissection taking place, only a few mediastinal nodes are being removed. In many cases dissecting a few extra nodes may mean the difference between confirming a stage I diagnosis and a stage III.

Related Videos
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD